WHOLE SHINE MEDICAL 2026H1: Oral Medical Service Business Revenue Approaching RMB 300 Million, Up 2.43% Year-on-Year, with Delun Dental Achieving Turnaround to Profitability.

Source: Haochen Medical 2026 Interim Report

H1 2026 Net Loss Attributable to Shareholders Narrowed 40.95% YoY to RMB 14.0259 Million / Oral Medical Service Revenue Up 2.43% YoY / Delun Medical Achieved Net Profit of RMB 18.0438 Million, Turning Profit from Loss

DentalGoodNews｜On August 26, 2026, WHOLE SHINE MEDICAL TECHNOLOGY CO.,LTD. (hereinafter referred to as "WHOLE SHINE MEDICAL") released its 2026 semi-annual report. The report shows that the company achieved operating revenue of RMB 314 million in the first half of the year, a year-on-year increase of 0.14%; net profit attributable to shareholders of the parent company recorded a loss of RMB 14.0259 million, narrowing the loss by 40.95% year-on-year. After deducting non-recurring gains and losses, net profit attributable to shareholders of the parent company recorded a loss of RMB 14.1131 million, narrowing the loss by 40.09% year-on-year.

Source: Haochen Medical 2026 Interim Report

According to previous reports by DGN, WHOLE SHINE MEDICAL disclosed in its 2026 first-half performance forecast that the improvement in profitability of its oral medical service business was the primary reason for the overall loss reduction. During the reporting period, WHOLE SHINE MEDICAL's oral medical service business generated revenue of RMB 296 million, a year-on-year increase of 2.43%, with its share of total revenue rising to 94.09%.

In terms of profitability, the gross margin of WHOLE SHINE MEDICAL's oral medical service business stood at 53.49%, up 9.88 percentage points from the same period last year. The company stated that Delun Medical continued to advance cost control measures, with various costs including medical consumables, labor costs, and rent all declining. In contrast, its permanent magnet switch business was affected by weak market demand, with revenue declining by RMB 26.22 million to RMB 17.7902 million, and gross margin also decreasing by 4.65 percentage points year-on-year.

Guangdong Delun Medical Group Co., Ltd. (hereinafter referred to as "Delun Medical"), the core controlling subsidiary of WHOLE SHINE MEDICAL, achieved a net profit of RMB 18.0438 million during the reporting period, an increase of RMB 37.9348 million from the -RMB 19.8910 million in the same period last year, turning from loss to profit. Delun Medical currently operates 28 chain clinics with an operating area exceeding 40,000 square meters and over 500 dental chairs. Its business covers four cities: Guangzhou, Foshan, Zhaoqing, and Huizhou, with a team comprising more than 200 licensed dentists and over 420 nursing staff.

The company stated that during the reporting period, Delun Medical continued to advance the renovation and upgrade of its older clinics. After the upgrade of Delun Yuebao Clinic, its area increased by more than 400 square meters and the number of dental chairs increased from 19 to 28. Additionally, the feasibility study for the Zhongshan Clinic has been completed, with a total area exceeding 1,500 square meters and a planned 26 dental chairs, pushing the chain network into the "five-city chain" stage.

Source: Haochen Medical 2026 Interim Report

On the expense side, selling expenses in the first half of 2026 amounted to RMB 76.1769 million, down 0.99% year-on-year; administrative expenses were RMB 68.9398 million, up 0.25% year-on-year; financial expenses were RMB 18.4633 million, down 10.57% year-on-year, primarily due to reduced borrowing interest. R&D investment was RMB 5.1663 million, down 35.15% year-on-year, mainly due to reduced R&D expenditure.

In terms of financial position, WHOLE SHINE MEDICAL's net cash flow from operating activities was RMB 10.4319 million, an increase of 137.81% compared to the same period last year, mainly attributable to increased cash inflows from the growth of its oral medical business. As of the end of the reporting period, the company's total assets stood at RMB 1.332 billion, with net assets attributable to shareholders of the listed company at RMB 261 million.

According to the report, the audit firm issued a qualified opinion on the company's 2025 annual financial statements, primarily concerning the lack of audit evidence for the carrying amount of its long-term equity investment in Fushun Bank. In addition, due to a contract dispute with Jinhaitang Asset Management, WHOLE SHINE MEDICAL's 6.68% equity stake in Fushun Bank will be subject to online judicial auction from August 24-27, 2026. If the auction is completed and the transfer is registered, the company's long-term equity investment amount will be correspondingly reduced.